Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|November 1, 1994
Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophagesA Vecchiarelli, D Pietrella, M Dottorini, et al.
Giornale Italiano Di Cardiologia|January 1, 1980
[The genetic incidence on QT interval values in ECG (author's transl)]G Giuliano, G Brenci, P Fragòla, et al.
European Journal of Immunology|March 4, 1998
Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytesA Vecchiarelli, C Monari, C Retini, et al.
American Journal of Respiratory Cell and Molecular Biology|August 1, 1994
Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infectionA Vecchiarelli, M Dottorini, D Pietrella, et al.
AIDS (London, England)|December 28, 2000
Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapyC Monari, A Casadevall, F Baldelli, et al.
Clinical and Experimental Immunology|May 25, 2011
A critical role for FcgammaRIIB in up-regulation of Fas ligand induced by a microbial polysaccharideM Piccioni, C Monari, S Bevilacqua, et al.
Infection and Immunity|August 1, 1995
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytesA Vecchiarelli, C Retini, D Pietrella, et al.
The Journal of Infection|February 12, 1998
Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformansC Monari, F Baldelli, D Pietrella, et al.
The Journal of Infectious Diseases|June 1, 1995
Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDSA Vecchiarelli, C Monari, F Baldelli, et al.
AIDS (London, England)|May 1, 1996
Inhibition of fungicidal activity of polymorphonuclear leukocytes from HIV-infected patients by interleukin (IL)-4 and IL-10C Tascini, F Baldelli, C Monari, et al.
Pageof 4